drugset / Trial / NCT06924658

Metformin in Safety and Efficacy in Gouty Patients

NCT06924658 ↗

Phase 2 Recruiting 70 enrolled Mostafa Bahaa
RandomizedParallel-groupDouble-blindTreatment

Summary

The most frequent crystal arthropathy is gout, which is also the most prevalent cause of inflammatory arthritis. Gouty Patients frequently have excruciating pain and swelling in their joints. Gout is linked to decreased health-related quality of life and functional disability. Gout and its associated diseases have been shown to have a significant impact on patients mortality and morbidities. Metformin, a biguanide, is used to manage diabetes by reducing insulin resistance and preventing comorbidities such as cerebrovascular and coronary artery disease, as well as providing renal protection to diabetic nephropathy patients

Timeline

Start
2025-04-20
Primary completion
2026-11-20
Completion
2026-11-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 1000 mg —

Indications